Skip Navigation LinksDPH-06-006-Raw-Gulf-Oysters

Office of Regulations

Disclaimer: If you have difficulty accessing documents, please contact the Office of Regulations staff of CDPH at (916) 558-1710 or to request this information in an alternate format.

DPH-06-006 Raw Gulf Oysters

Information and documentation pertaining to this regulatory proposal are listed here.

Sections Affected

California Code of Regulations, Title 17
Sections: 13675, 13676

Schedule of Rulemaking Proceedings

Notice of Proposed Rulemaking Published:  June 27, 2014
California Regulatory Notice Register, 2014:  26-Z
Public Hearing Date: None Scheduled
Start of the 45-Day Written Public Comment Period:  June 27, 2014
Close of the 45-Day Written Public Comment Period:  August 11, 2014
Notice to Withdraw Rulemaking: 2014-1031-5 S
Notice of 15-Day Public Availability:  January 8, 2015 until 5:00 p.m. January 24, 2015
Office of Administrative Law File No.:  2015-0220-02 SR
Filed with Secretary of State:  February 27, 2015
Effective Date:  April 1, 2015

Status of the Proposal

The rulemaking is completed.

Inquiries regarding the contents of these regulations may be directed to:
Name: Pat Kennelly, Chief, Food Safety Section, California Department of Public Health's Food & Drug Branch
Phone: (916) 650-6598

Rulemaking Documentation

45-Day Public Comment Period Documentation

Notice of Proposed Rulemaking
Initial Statement of Reasons
Proposed Regulation Text

15-Day Public Availability Documentation

Notice of 15-Day Public Availability
Notice of changes to proposed regulations regarding Raw Gulf Oysters.
Supplement to the Statement of Reasons
Describes the necessity for the changes.
Methodology of Changes to Proposed Regulations
Methodology and Regulation Text.
Document Incorporated by Reference
Document added to the regulation text as "Incorporated by Reference."

Final Rulemaking Documentation

Updated Informative Digest
Final Statement of Reasons
Final Regulation Text
FDA Bacteriological Analystical Manual (BAM), Seventh Edition, 1992
Vibrio vulnificus EIA procedure of Tamplin, et al. as described in Chapter 9 of the FDA BAM.

Page Last Updated :